8-KExhibits & Filings

WELLS FARGO & COMPANY/MN 8-K Report, Exhibit Filing (Apr 10, 2013)

Filed April 10, 2013For Securities:WFCWFC-PDWFC-PCWFC-PYWFC-PAWFC-PLWFCNPWFC-PZ

Summary

Wells Fargo & Company filed an 8-K on April 10, 2013, to report the issuance of new financial instruments: Medium-Term Notes, Series K, 0% Optionally Exchangeable Securities due January 24, 2020. These notes offer investors the unique option to exchange them for either the common stock of Apple Inc. or the cash equivalent of that stock. This filing is primarily to include the form of the note and legal opinions from external counsel regarding its terms and tax implications.

Key Highlights

  • 1Wells Fargo issued new "0% Optionally Exchangeable Securities" due January 24, 2020.
  • 2These securities are exchangeable into Apple Inc. common stock or its cash value.
  • 3The filing includes the form of the note, providing details on its structure and terms.
  • 4Legal opinions from Faegre Baker Daniels LLP and Sullivan & Cromwell LLP are filed as exhibits.
  • 5The filing is related to a Registration Statement on Form S-3 previously filed by Wells Fargo.
  • 6The 0% interest rate on the notes is a notable feature.
  • 7The exchangeability feature ties the note's value to the performance of Apple Inc. stock.

Frequently Asked Questions

These are debt instruments issued by Wells Fargo that mature on January 24, 2020. Their key feature is that they can be exchanged by the holder for either shares of Apple Inc. common stock or the cash value of those shares at the time of exchange.

The 0% interest rate means that the securities will not pay periodic coupon interest. The return for investors will primarily come from the potential appreciation of Apple Inc. stock if they choose to exercise the exchange option.

While the filing doesn't explicitly state the reason, this structure is often used to offer investors exposure to a specific company's stock performance while providing a debt instrument wrapper. It could be a way for Wells Fargo to meet investor demand for such exposure or to manage its own funding needs with an attractive product.

The filed exhibits include the official document outlining the terms and conditions of the Medium-Term Notes, Series K (Exhibit 4.1), along with legal opinions from counsel confirming aspects of the notes and their tax treatment (Exhibits 5.1 and 8.1), and their consents (Exhibits 23.1 and 23.2).